Profil
Olivia Zetter is the founder of Vilya, Inc., founded in 2022.
Current jobs include Director at Paratus Sciences Corp., Strategic Advisor & Venture Partner at ARCH Venture Partners LLC since 2022, Advisor at R Squared Ventures LLC since 2022, Head-Government Affairs & Ai Strategy at National Resilience, Inc., and Venture Partner at R Squared Venture Capital.
Former job includes Director at National Security Commission on Artificial Intelligence from 2019 to 2020.
Education includes undergraduate studies at American University and graduate studies at Harvard Kennedy School of Government.
Postes actifs de Olivia Zetter
| Sociétés | Poste | Début |
|---|---|---|
National Resilience, Inc.
National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | Corporate Officer/Principal | - |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Consultant / Advisor | 01/05/2022 |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Rsquared Fund Management LLC
Rsquared Fund Management LLC Investment ManagersFinance Rsquared invests in companies located in the United States. The firm focus on broad range of sectors and industries. It provide financing for early stage capital requirements. | Private Equity Investor | - |
R Squared Ventures LLC
R Squared Ventures LLC Packaged SoftwareTechnology Services Provides healthcare services | Consultant / Advisor | 01/05/2022 |
Anciens postes connus de Olivia Zetter
| Sociétés | Poste | Fin |
|---|---|---|
National Security Commission on Artificial Intelligence | Directeur/Membre du Conseil | 01/08/2020 |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Fondateur | - |
Formation de Olivia Zetter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
American University
American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Kennedy School of Government
Harvard Kennedy School of Government Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
R Squared Ventures LLC
R Squared Ventures LLC Packaged SoftwareTechnology Services Provides healthcare services | Technology Services |
National Resilience, Inc.
National Resilience, Inc. BiotechnologyHealth Technology Operates as a biomanufacturing company that develops and produces medicines | Health Technology |
National Security Commission on Artificial Intelligence | |
Rsquared Fund Management LLC
Rsquared Fund Management LLC Investment ManagersFinance Rsquared invests in companies located in the United States. The firm focus on broad range of sectors and industries. It provide financing for early stage capital requirements. | Finance |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Health Technology |
















